RE:RE:RE:Avicanna financials released today Things looking upWhat i'm saying is I speculate AVCN and MEDIF had discussion about M&A. They could not agree on the price. They both think they are undervalued. MEDIF knows they are really tight on money and might wait for a better deal.
And we're doing that -- we're doing that on a licensing agreement perspective and looking at many deals with companies to do that, not in a full M&A perspective but also that's certainly one of the things and one of the synergy opportunities we look at as we consider M&A. And I'd just say we'll be really thoughtful as we were with VIVO.